Phase 2 Metastatic Triple-negative Breast Cancer trials recruiting now

All Metastatic Triple-negative Breast Cancer trials, every phase

Phase 2 Metastatic Triple-negative Breast Cancer trials

• A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
  NCT07544056 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
  NCT05570253 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Saci Nivo Rela for TNBC
  NCT06963905 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
  NCT07011654 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer.
  NCT06851299 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.